Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    February 2017
  1. CAMERON D, Piccart-Gebhart MJ, Gelber RD, Procter M, et al
    11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
    Lancet. 2017 Feb 16. pii: S0140-6736(16)32616.
    PubMed     Text format     Abstract available


  2. SPECHT JM, Davidson NE
    Optimal duration of trastuzumab for early HER2-positive breast cancer.
    Lancet. 2017 Feb 16. pii: S0140-6736(17)30322.
    PubMed     Text format    


    January 2017
  3. THE LANCET
    Trastuzumab emtansine and cost-based decision making.
    Lancet. 2017;389:2.
    PubMed     Text format    


    November 2016
  4. CRISTOFANILLI M
    Metastatic breast cancer: focus on endocrine sensitivity.
    Lancet. 2016 Nov 28. pii: S0140-6736(16)32418.
    PubMed     Text format    


  5. ROBERTSON JF, Bondarenko IM, Trishkina E, Dvorkin M, et al
    Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
    Lancet. 2016 Nov 28. pii: S0140-6736(16)32389.
    PubMed     Text format     Abstract available


  6. HARBECK N, Gnant M
    Breast cancer.
    Lancet. 2016 Nov 16. pii: S0140-6736(16)31891.
    PubMed     Text format     Abstract available


    September 2016
  7. THE LANCET
    Balancing the benefits and risks of choice.
    Lancet. 2016;388:1129.
    PubMed     Text format    


    June 2016
  8. OHUCHI N, Suzuki A, Yamamoto S, Kuriyama S, et al
    Adjunctive ultrasonography for breast cancer screening - Authors' reply.
    Lancet. 2016;387:2381-2.
    PubMed     Text format    


  9. AUTIER P, Boniol M
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2380.
    PubMed     Text format    


  10. FUJITA T
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2380-1.
    PubMed     Text format    


  11. DALE A, Slade E, Heneghan C
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2379-80.
    PubMed     Text format    


    May 2016
  12. BERNSTEIN M
    Intraoperative radiation therapy for breast cancer: a patient's view.
    Lancet. 2016;387:1904-5.
    PubMed     Text format    


    April 2016
  13. STRNAD V, Uter W, Polgar C
    Partial breast irradiation and the GEC-ESTRO trial - Authors' reply.
    Lancet. 2016;387:1718-9.
    PubMed     Text format    


  14. VICINI F, Shah C, Arthur D, Khan A, et al
    Partial breast irradiation and the GEC-ESTRO trial.
    Lancet. 2016;387:1717-8.
    PubMed     Text format    


  15. VAIDYA JS, Bulsara M, Wenz F, Tobias JS, et al
    Partial breast irradiation and the GEC-ESTRO trial.
    Lancet. 2016;387:1717.
    PubMed     Text format    


    February 2016
  16. JOHNSTON SR
    Endocrine treatment for ductal carcinoma in situ: balancing risks and benefits.
    Lancet. 2016;387:819-21.
    PubMed     Text format    


    January 2016
  17. VICTORA CG, Bahl R, Barros AJ, Franca GV, et al
    Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect.
    Lancet. 2016;387:475-90.
    PubMed     Text format     Abstract available


  18. STRNAD V, Ott OJ, Hildebrandt G, Kauer-Dorner D, et al
    5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a
    Lancet. 2016;387:229-38.
    PubMed     Text format     Abstract available


  19. COLES CE, Yarnold JR
    Accelerated partial breast irradiation: the new standard?
    Lancet. 2016;387:201-2.
    PubMed     Text format    


    December 2015
  20. FORBES JF, Sestak I, Howell A, Bonanni B, et al
    Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
    Lancet. 2015 Dec 11. pii: S0140-6736(15)01129.
    PubMed     Text format     Abstract available


  21. GANZ PA, Cecchini RS, Julian TB, Margolese RG, et al
    Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Lancet. 2015 Dec 10. pii: S0140-6736(15)01169.
    PubMed     Text format     Abstract available


  22. MARGOLESE RG, Cecchini RS, Julian TB, Ganz PA, et al
    Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Lancet. 2015 Dec 10. pii: S0140-6736(15)01168.
    PubMed     Text format     Abstract available


    November 2015
  23. GNANT M
    Denosumab and fracture risk in women with breast cancer - Author's reply.
    Lancet. 2015;386:2057-8.
    PubMed     Text format    


  24. BOISSIEU PD, Trenque T
    Denosumab and fracture risk in women with breast cancer.
    Lancet. 2015;386:2057.
    PubMed     Text format    


  25. FAROOKI A, Fornier M
    Denosumab and fracture risk in women with breast cancer.
    Lancet. 2015;386:2056-7.
    PubMed     Text format    


  26. THE LANCET
    HRT for menopause: a NICE treatment?
    Lancet. 2015;386:2030.
    PubMed     Text format    


  27. OHUCHI N, Suzuki A, Sobue T, Kawai M, et al
    Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.
    Lancet. 2015 Nov 4. pii: S0140-6736(15)00774.
    PubMed     Text format     Abstract available


  28. YAFFE MJ, Jong RA
    Adjunctive ultrasonography in breast cancer screening.
    Lancet. 2015 Nov 4. pii: S0140-6736(15)00787.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: